Large Language Models in Diabetes Management: The Need for Human and Artificial Intelligence Collaboration

Juliessa M Pavon^{1

2

3}, David Schlientz¹, Matthew L Maciejewski^{4

5

6}, Nicoleta Economou-Zavlanos⁷, Richard H Lee^{3

8}

Affiliations

¹ Division of Geriatrics, Department of Medicine, Duke University, Durham, NC.
² Geriatric Research Education Clinical Center, Durham Veteran Affairs Health Care System, Durham, NC.
³ Center for the Study of Aging and Human Development, Duke University, Durham, NC.
⁴ Department of Population Health, Duke University, Durham, NC.
⁵ Division of General Internal Medicine, Department of Medicine, Duke University, Durham, NC.
⁶ Center of Innovation to Accelerate Discovery & Practice Transformation, Durham Veterans Affairs Medical Center, Durham, NC.
⁷ Duke AI Health, Duke University, Durham, NC.
⁸ Division of Endocrinology, Department of Medicine, Duke University, Durham, NC.

Editorial

Juliessa M Pavon et al. Diabetes Care. 2025.

. 2025 Feb 1;48(2):182-184.

doi: 10.2337/dci24-0079.

Juliessa M Pavon^{1

2

3}, David Schlientz¹, Matthew L Maciejewski^{4

5

6}, Nicoleta Economou-Zavlanos⁷, Richard H Lee^{3

8}

¹ Division of Geriatrics, Department of Medicine, Duke University, Durham, NC.
² Geriatric Research Education Clinical Center, Durham Veteran Affairs Health Care System, Durham, NC.
³ Center for the Study of Aging and Human Development, Duke University, Durham, NC.
⁴ Department of Population Health, Duke University, Durham, NC.
⁵ Division of General Internal Medicine, Department of Medicine, Duke University, Durham, NC.
⁶ Center of Innovation to Accelerate Discovery & Practice Transformation, Durham Veterans Affairs Medical Center, Durham, NC.
⁷ Duke AI Health, Duke University, Durham, NC.
⁸ Division of Endocrinology, Department of Medicine, Duke University, Durham, NC.

No abstract available

Conflict of interest statement

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Large Language Model GPT-4 Compared to Endocrinologist Responses on Initial Choice of Glucose-Lowering Medication Under Conditions of Clinical Uncertainty.
Flory JH, Ancker JS, Kim SYH, Kuperman G, Petrov A, Vickers A. Flory JH, et al. Diabetes Care. 2025 Feb 1;48(2):185-192. doi: 10.2337/dc24-1067. Diabetes Care. 2025. PMID: 39250109

1. Flory JH, Ancker JS, Kim SYH, Kuperman G, Petrov A, Vickers A. Large language model GPT-4 compared to endocrinologist responses on initial choice of antidiabetic medication under conditions of clinical uncertainty. Diabetes Care 2025;48:185–192 - PMC - PubMed
1. Davies MJ, Aroda VR, Collins BS, et al. . Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2022;45:2753–2786 - PMC - PubMed
1. Samson SL, Vellanki P, Blonde L, et al. . American Association of Clinical Endocrinology consensus statement: comprehensive type 2 diabetes management algorithm - 2023 update. Endocr Pract 2023;29:305–340 - PubMed
1. LeRoith D, Biessels GJ, Braithwaite SS, et al. . Treatment of diabetes in older adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2019;104:1520–1574 - PMC - PubMed
1. American Diabetes Association Professional Practice Committee . Introduction and methodology: Standards of Care in Diabetes—2024. Diabetes Care 2024;47(Suppl. 1):S1–S4 - PubMed